{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:18:02Z","timestamp":1792023482847,"version":"4.4.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T00:00:00Z","timestamp":1732838400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T00:00:00Z","timestamp":1732838400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"National Cancer Institute","award":["5R01CA1661470-05"],"award-info":[{"award-number":["5R01CA1661470-05"]}]},{"name":"National Cancer Institute","award":["K07CA211955"],"award-info":[{"award-number":["K07CA211955"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s00520-024-09030-z","type":"journal-article","created":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T07:19:25Z","timestamp":1732864765000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["A qualitative study of attitudes and perceptions of smoking cessation medication among patients with cancer"],"prefix":"10.1007","volume":"32","author":[{"given":"Jennifer","family":"Gittleman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna G.","family":"Cloutier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elyse R.","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Autumn","family":"Rasmussen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin","family":"Ponzani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea H.","family":"Weinberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie S.","family":"Ostroff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giselle","family":"Perez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,29]]},"reference":[{"key":"9030_CR1","unstructured":"National Center for Chronic Disease Prevention and Health Promotion (US) Office on Smoking and Health. The health consequences of smoking\u201450 years of progress: a report of the surgeon general. Centers for Disease Control and Prevention (US); 2014. Accessed January 8, 2024. http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK179276\/"},{"key":"9030_CR2","doi-asserted-by":"publisher","unstructured":"Vidrine JI, Simmons VN, Vidrine DJ. Improving smoking cessation support for patients with cancer. JCO Oncol Pract. Published online January 5, 2024:OP.23.00708. https:\/\/doi.org\/10.1200\/OP.23.00708","DOI":"10.1200\/OP.23.00708"},{"key":"9030_CR3","doi-asserted-by":"publisher","first-page":"102237","DOI":"10.1016\/j.canep.2022.102237","volume":"80","author":"Z Feuer","year":"2022","unstructured":"Feuer Z, Michael J, Morton E et al (2022) Systematic review of smoking relapse rates among cancer survivors who quit at the time of cancer diagnosis. Cancer Epidemiol 80:102237. https:\/\/doi.org\/10.1016\/j.canep.2022.102237","journal-title":"Cancer Epidemiol"},{"key":"9030_CR4","unstructured":"NCCN (2022) Smoking Cessation. National Comprehensive Cancer Network"},{"key":"9030_CR5","unstructured":"U.S. National Cancer Institute. Treating smoking in cancer patients: an essential component of cancer care. U.S. Department of Health and Human Services, National Institutes of Health, National Cancer Institute; 2022."},{"issue":"9","key":"9030_CR6","doi-asserted-by":"publisher","first-page":"e1912251","DOI":"10.1001\/jamanetworkopen.2019.12251","volume":"2","author":"PM Cinciripini","year":"2019","unstructured":"Cinciripini PM, Karam-Hage M, Kypriotakis G et al (2019) Association of a comprehensive smoking cessation program with smoking abstinence among patients with cancer. JAMA Netw Open 2(9):e1912251. https:\/\/doi.org\/10.1001\/jamanetworkopen.2019.12251","journal-title":"JAMA Netw Open"},{"issue":"6","key":"9030_CR7","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1056\/NEJMp1813913","volume":"380","author":"RT Croyle","year":"2019","unstructured":"Croyle RT, Morgan GD, Fiore MC (2019) Addressing a core gap in cancer care \u2014 the NCI Moonshot Program to help oncology patients stop smoking. N Engl J Med 380(6):512\u2013515. https:\/\/doi.org\/10.1056\/NEJMp1813913","journal-title":"N Engl J Med"},{"issue":"6","key":"9030_CR8","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1001\/jama.2022.0395","volume":"327","author":"NA Rigotti","year":"2022","unstructured":"Rigotti NA, Kruse GR, Livingstone-Banks J, Hartmann-Boyce J (2022) Treatment of tobacco smoking: A review. JAMA 327(6):566. https:\/\/doi.org\/10.1001\/jama.2022.0395","journal-title":"JAMA"},{"issue":"5","key":"9030_CR9","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1097\/ADM.0000000000001171","volume":"17","author":"XEF Shang","year":"2023","unstructured":"Shang XEF, Guo K et al (2023) Effectiveness and safety of varenicline for smoking cessation: An overview and meta-analysis. J Addict Med 17(5):536\u2013543. https:\/\/doi.org\/10.1097\/ADM.0000000000001171","journal-title":"J Addict Med"},{"key":"9030_CR10","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.addbeh.2019.04.003","volume":"95","author":"AJ Carroll","year":"2019","unstructured":"Carroll AJ, Kim K, Miele A et al (2019) Longitudinal associations between smoking and affect among cancer patients using varenicline to quit smoking. Addict Behav 95:206\u2013210. https:\/\/doi.org\/10.1016\/j.addbeh.2019.04.003","journal-title":"Addict Behav"},{"issue":"8","key":"9030_CR11","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1093\/ntr\/nty133","volume":"21","author":"G Crawford","year":"2019","unstructured":"Crawford G, Weisbrot J, Bastian J et al (2019) Predictors of varenicline adherence among cancer patients treated for tobacco dependence and its association with smoking cessation. Nicotine Tob Res 21(8):1135\u20131139. https:\/\/doi.org\/10.1093\/ntr\/nty133","journal-title":"Nicotine Tob Res"},{"issue":"3","key":"9030_CR12","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1002\/pon.4978","volume":"28","author":"R Schnoll","year":"2019","unstructured":"Schnoll R, Leone F, Veluz-Wilkins A et al (2019) A randomized controlled trial of 24 weeks of varenicline for tobacco use among cancer patients: efficacy, safety, and adherence. Psychooncology 28(3):561\u2013569. https:\/\/doi.org\/10.1002\/pon.4978","journal-title":"Psychooncology"},{"issue":"2","key":"9030_CR13","doi-asserted-by":"publisher","first-page":"e261","DOI":"10.1200\/OP.20.01095","volume":"18","author":"JL Burris","year":"2022","unstructured":"Burris JL, Borger TN, Shelton BJ et al (2022) Tobacco use and tobacco treatment referral response of patients with cancer: implementation outcomes at a National Cancer Institute-Designated Cancer Center. JCO Oncol Pract 18(2):e261\u2013e270. https:\/\/doi.org\/10.1200\/OP.20.01095","journal-title":"JCO Oncol Pract"},{"issue":"6","key":"9030_CR14","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1007\/s13187-021-02068-1","volume":"37","author":"S Schiavon","year":"2022","unstructured":"Schiavon S, Davies E, Mildrum Chana S et al (2022) Oncology patient smoking cessation treatment preferences: perceptions across former and current cigarette smokers. J Cancer Educ 37(6):1975\u20131981. https:\/\/doi.org\/10.1007\/s13187-021-02068-1","journal-title":"J Cancer Educ"},{"key":"9030_CR15","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.abrep.2018.06.006","volume":"8","author":"G Crawford","year":"2018","unstructured":"Crawford G, Jao N, Peng AR et al (2018) The association between self-reported varenicline adherence and varenicline blood levels in a sample of cancer patients receiving treatment for tobacco dependence. Addict Behav Rep 8:46\u201350. https:\/\/doi.org\/10.1016\/j.abrep.2018.06.006","journal-title":"Addict Behav Rep"},{"issue":"14","key":"9030_CR16","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1001\/jama.2020.14581","volume":"324","author":"ER Park","year":"2020","unstructured":"Park ER, Perez GK, Regan S et al (2020) Effect of sustained smoking cessation counseling and provision of medication vs shorter-term counseling and medication advice on smoking abstinence in patients recently diagnosed with cancer: a randomized clinical trial. JAMA 324(14):1406. https:\/\/doi.org\/10.1001\/jama.2020.14581","journal-title":"JAMA"},{"issue":"2","key":"9030_CR17","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1093\/ntr\/ntab139","volume":"24","author":"GE Puleo","year":"2022","unstructured":"Puleo GE, Borger T, Bowling WR, Burris JL (2022) The state of the science on cancer diagnosis as a \u201cteachable moment\u201d for smoking cessation: a scoping review. Nicotine Tob Res 24(2):160\u2013168. https:\/\/doi.org\/10.1093\/ntr\/ntab139","journal-title":"Nicotine Tob Res"},{"issue":"10","key":"9030_CR18","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1093\/ntr\/ntx210","volume":"20","author":"LR Pacek","year":"2018","unstructured":"Pacek LR, McClernon FJ, Bosworth HB (2018) Adherence to pharmacological smoking cessation interventions: a literature review and synthesis of correlates and barriers. Nicotine Tob Res 20(10):1163\u20131172. https:\/\/doi.org\/10.1093\/ntr\/ntx210","journal-title":"Nicotine Tob Res"},{"key":"9030_CR19","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.cct.2016.07.016","volume":"50","author":"ER Park","year":"2016","unstructured":"Park ER, Ostroff JS, Perez GK et al (2016) Integrating tobacco treatment into cancer care: study protocol for a randomized controlled comparative effectiveness trial. Contemp Clin Trials 50:54\u201365. https:\/\/doi.org\/10.1016\/j.cct.2016.07.016","journal-title":"Contemp Clin Trials"},{"key":"9030_CR20","unstructured":"Miles MB and Huberman AM (1994) Qualitative data analysis: an expanded sourcebook. 2. ed., [Nachdr.]. Sage"},{"issue":"5","key":"9030_CR21","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1093\/ntr\/ntr003","volume":"13","author":"SL Catz","year":"2011","unstructured":"Catz SL, Jack LM, McClure JB et al (2011) Adherence to varenicline in the COMPASS Smoking Cessation Intervention Trial. Nicotine Tob Res 13(5):361\u2013368. https:\/\/doi.org\/10.1093\/ntr\/ntr003","journal-title":"Nicotine Tob Res"},{"key":"9030_CR22","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.addbeh.2016.12.008","volume":"67","author":"V Kushnir","year":"2017","unstructured":"Kushnir V, Sproule BA, Cunningham JA (2017) Mailed distribution of free nicotine patches without behavioral support: PrediCTORS OF USE and cessation. Addict Behav 67:73\u201378. https:\/\/doi.org\/10.1016\/j.addbeh.2016.12.008","journal-title":"Addict Behav"},{"key":"9030_CR23","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.addbeh.2016.05.012","volume":"61","author":"SC Voci","year":"2016","unstructured":"Voci SC, Zawertailo LA, Hussain S, Selby PL (2016) Association between adherence to free nicotine replacement therapy and successful quitting. Addict Behav 61:25\u201331. https:\/\/doi.org\/10.1016\/j.addbeh.2016.05.012","journal-title":"Addict Behav"},{"issue":"8","key":"9030_CR24","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1111\/ijcp.12644","volume":"69","author":"JM Yingst","year":"2015","unstructured":"Yingst JM, Veldheer S, Hrabovsky S, Sciamanna C, Foulds J (2015) Reasons for non-adherence to nicotine patch therapy during the first month of a quit attempt. Int J Clin Pract 69(8):883\u2013888. https:\/\/doi.org\/10.1111\/ijcp.12644","journal-title":"Int J Clin Pract"},{"key":"9030_CR25","doi-asserted-by":"publisher","unstructured":"Incirliova District Health Directorate, Aydin, Turkey, Aksel O, Kucuktepe N, et al. Providing free access to smoking cessation medications: does it have an impact on the treatment adherence and success of smoking cessation? Turk Thorac J. 2021;22(3):224\u2013230. https:\/\/doi.org\/10.5152\/TurkThoracJ.2021.20124","DOI":"10.5152\/TurkThoracJ.2021.20124"},{"issue":"4","key":"9030_CR26","doi-asserted-by":"publisher","first-page":"272","DOI":"10.3322\/caac.21231","volume":"64","author":"M Karam-Hage","year":"2014","unstructured":"Karam-Hage M, Cinciripini PM, Gritz ER (2014) Tobacco use and cessation for cancer survivors: an overview for clinicians. CA Cancer J Clin 64(4):272\u2013290. https:\/\/doi.org\/10.3322\/caac.21231","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"9030_CR27","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.amepre.2007.11.010","volume":"34","author":"EK Burns","year":"2008","unstructured":"Burns EK, Levinson AH (2008) Discontinuation of nicotine replacement therapy among smoking-cessation attempters. Am J Prev Med 34(3):212\u2013215. https:\/\/doi.org\/10.1016\/j.amepre.2007.11.010","journal-title":"Am J Prev Med"},{"issue":"6","key":"9030_CR28","doi-asserted-by":"publisher","first-page":"592","DOI":"10.18553\/jmcp.2014.20.6.592","volume":"20","author":"BT Suehs","year":"2014","unstructured":"Suehs BT, Davis C, Galaznik A, Joshi AV, Zou KH, Patel NC (2014) Association of out-of-pocket pharmacy costs with adherence to varenicline. J Manag Care Pharm 20(6):592\u2013600. https:\/\/doi.org\/10.18553\/jmcp.2014.20.6.592","journal-title":"J Manag Care Pharm"},{"key":"9030_CR29","doi-asserted-by":"publisher","unstructured":"Van Boven JFM, Vemer P (2015) Higher adherence during reimbursement of pharmacological smoking cessation treatments. Nicotine Tob Res. Published online March 16, 2015:ntv064. https:\/\/doi.org\/10.1093\/ntr\/ntv064","DOI":"10.1093\/ntr\/ntv064"},{"issue":"6","key":"9030_CR30","doi-asserted-by":"publisher","first-page":"e2216362","DOI":"10.1001\/jamanetworkopen.2022.16362","volume":"5","author":"DE Levy","year":"2022","unstructured":"Levy DE, Regan S, Perez GK et al (2022) Cost-effectiveness of implementing smoking cessation interventions for patients with cancer. JAMA Netw Open 5(6):e2216362. https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.16362","journal-title":"JAMA Netw Open"},{"issue":"10","key":"9030_CR31","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1002\/pon.3291","volume":"22","author":"H Cheng","year":"2013","unstructured":"Cheng H, Yang Z, Dong B et al (2013) Chemotherapy-induced prospective memory impairment in patients with breast cancer. Psychooncology 22(10):2391\u20132395. https:\/\/doi.org\/10.1002\/pon.3291","journal-title":"Psychooncology"},{"issue":"1","key":"9030_CR32","doi-asserted-by":"publisher","first-page":"205510291983223","DOI":"10.1177\/2055102919832234","volume":"6","author":"FM Henderson","year":"2019","unstructured":"Henderson FM, Cross AJ, Baraniak AR (2019) \u2018A new normal with chemobrain\u2019: experiences of the impact of chemotherapy-related cognitive deficits in long-term breast cancer survivors. Health Psychol Open 6(1):205510291983223. https:\/\/doi.org\/10.1177\/2055102919832234","journal-title":"Health Psychol Open"},{"key":"9030_CR33","doi-asserted-by":"publisher","unstructured":"Ren X, Boriero D, Chaiswing L, Bondada S, St. Clair DK, Butterfield DA (2019) Plausible biochemical mechanisms of chemotherapy-induced cognitive impairment (\u201cchemobrain\u201d), a condition that significantly impairs the quality of life of many cancer survivors. Biochim Biophys Acta BBA - Mol Basis Dis. 2019;1865(6):1088\u20131097. https:\/\/doi.org\/10.1016\/j.bbadis.2019.02.007","DOI":"10.1016\/j.bbadis.2019.02.007"},{"issue":"3","key":"9030_CR34","doi-asserted-by":"publisher","first-page":"226","DOI":"10.3747\/co.25.3921","volume":"25","author":"SM Davidson","year":"2018","unstructured":"Davidson SM, Boldt RG, Louie AV (2018) How can we better help cancer patients quit smoking? The London Regional Cancer Program experience with smoking cessation. Curr Oncol 25(3):226\u2013230. https:\/\/doi.org\/10.3747\/co.25.3921","journal-title":"Curr Oncol"},{"issue":"2","key":"9030_CR35","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1002\/ijc.27617","volume":"132","author":"GW Warren","year":"2013","unstructured":"Warren GW, Kasza KA, Reid ME, Cummings KM, Marshall JR (2013) Smoking at diagnosis and survival in cancer patients. Int J Cancer 132(2):401\u2013410. https:\/\/doi.org\/10.1002\/ijc.27617","journal-title":"Int J Cancer"},{"issue":"11","key":"9030_CR36","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1097\/JTO.0000000000000659","volume":"10","author":"GW Warren","year":"2015","unstructured":"Warren GW, Dibaj S, Hutson A, Cummings KM, Dresler C, Marshall JR (2015) Identifying targeted strategies to improve smoking cessation support for cancer patients. J Thorac Oncol 10(11):1532\u20131537. https:\/\/doi.org\/10.1097\/JTO.0000000000000659","journal-title":"J Thorac Oncol"},{"issue":"4","key":"9030_CR37","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/j.addbeh.2006.06.021","volume":"32","author":"S Shiffman","year":"2007","unstructured":"Shiffman S, Ferguson SG, Hellebusch SJ (2007) Physicians\u2019 counseling of patients when prescribing nicotine replacement therapy. Addict Behav 32(4):728\u2013739. https:\/\/doi.org\/10.1016\/j.addbeh.2006.06.021","journal-title":"Addict Behav"},{"issue":"1","key":"9030_CR38","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s10389-009-0277-2","volume":"18","author":"IT Croghan","year":"2010","unstructured":"Croghan IT, Hurt RD, Ebbert JO et al (2010) Racial differences in smoking abstinence rates in a multicenter, randomized, open-label trial in the United States. J Public Health 18(1):59\u201368. https:\/\/doi.org\/10.1007\/s10389-009-0277-2","journal-title":"J Public Health"},{"issue":"10","key":"9030_CR39","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1634\/theoncologist.2011-0114","volume":"16","author":"ER Park","year":"2011","unstructured":"Park ER, Japuntich SJ, Traeger L, Cannon S, Pajolek H (2011) Disparities between blacks and whites in tobacco and lung cancer treatment. Oncologist 16(10):1428\u20131434. https:\/\/doi.org\/10.1634\/theoncologist.2011-0114","journal-title":"Oncologist"},{"issue":"8","key":"9030_CR40","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1093\/ntr\/ntr051","volume":"13","author":"KK Ryan","year":"2011","unstructured":"Ryan KK, Garrett-Mayer E, Alberg AJ, Cartmell KB, Carpenter MJ (2011) Predictors of cessation pharmacotherapy use among Black and Non-Hispanic White smokers. Nicotine Tob Res 13(8):646\u2013652. https:\/\/doi.org\/10.1093\/ntr\/ntr051","journal-title":"Nicotine Tob Res"},{"issue":"1","key":"9030_CR41","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1634\/theoncologist.2015-0325","volume":"21","author":"P Kumar","year":"2016","unstructured":"Kumar P, Gareen IF, Lathan C et al (2016) Racial differences in tobacco cessation and treatment usage after lung screening: an examination of the National Lung Screening Trial. Oncologist 21(1):40\u201349. https:\/\/doi.org\/10.1634\/theoncologist.2015-0325","journal-title":"Oncologist"},{"issue":"1","key":"9030_CR42","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1002\/cncr.21598","volume":"106","author":"ER Gritz","year":"2006","unstructured":"Gritz ER, Fingeret MC, Vidrine DJ, Lazev AB, Mehta NV, Reece GP (2006) Successes and failures of the teachable moment: Smoking cessation in cancer patients. Cancer 106(1):17\u201327. https:\/\/doi.org\/10.1002\/cncr.21598","journal-title":"Cancer"},{"issue":"1","key":"9030_CR43","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1200\/JOP.0912001","volume":"5","author":"L Burke","year":"2009","unstructured":"Burke L, Miller LA, Saad A, Abraham J (2009) Smoking behaviors among cancer survivors: an observational clinical study. J Oncol Pract 5(1):6\u20139. https:\/\/doi.org\/10.1200\/JOP.0912001","journal-title":"J Oncol Pract"},{"issue":"1","key":"9030_CR44","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s12160-016-9834-4","volume":"51","author":"AJ Guimond","year":"2017","unstructured":"Guimond AJ, Croteau VA, Savard MH, Bernard P, Ivers H, Savard J (2017) Predictors of smoking cessation and relapse in cancer patients and effect on psychological variables: an 18-month observational study. Ann Behav Med 51(1):117\u2013127. https:\/\/doi.org\/10.1007\/s12160-016-9834-4","journal-title":"Ann Behav Med"},{"issue":"5","key":"9030_CR45","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1093\/ntr\/ntv177","volume":"18","author":"JS Ostroff","year":"2016","unstructured":"Ostroff JS, Copeland A, Borderud SP, Li Y, Shelley DR, Henschke CI (2016) Readiness of lung cancer screening sites to deliver smoking cessation treatment: current practices, organizational priority, and perceived barriers. Nicotine Tob Res 18(5):1067\u20131075. https:\/\/doi.org\/10.1093\/ntr\/ntv177","journal-title":"Nicotine Tob Res"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-024-09030-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-024-09030-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-024-09030-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,8]],"date-time":"2025-02-08T05:48:40Z","timestamp":1738993720000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-024-09030-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,29]]},"references-count":45,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["9030"],"URL":"https:\/\/doi.org\/10.1007\/s00520-024-09030-z","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,29]]},"assertion":[{"value":"4 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. The Massachusetts General Brigham institutional review board reviewed and approved this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}],"article-number":"836"}}